The virus like particles (VLP’s) market is projected to reach US$ 7,858.82 million by 2028 from US$ 4,601.84 million in 2021; it is expected to grow at a CAGR of 7.9% from 2021 to 2028. Consistent R&D activities prominently drive the growth of the overall market. VLPs have gained attention from many researchers, particularly virologists and immunologists. VLP-based vaccines are more immunogenic and safer than traditional vaccines as they cannot replicate, recombine, or undergo reassortment due to the lack of infectious DNA or RNA material. However, the feasibility of VLPs as antigen carriers is questionable and complicated due to associated difficulties which is resulting in the sluggish growth of the global market. Therefore, Frontiers S.A. report states that for mutation of the viruses coupled with its adjuvant effect and inflammatory response has to be evaluated by the researchers for development of each new VLP vaccine.
The global virus-like particles (VLP’s) market is segmented based on product type, source, and application. Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease. The hepatitis segment would account for a large market share during 2021-2028. For instance, as per the data published by the Hepatitis B Foundations in 2021, about two billion people are infected with the hepatitis B virus worldwide. To counter such situation utilization of commercialized VLPs vaccines proved effective for hepatitis treatment. Examples of commercialized VLP vaccines are “Recombivax" and "Engerix". These two are the recently commercialized VLP-based vaccines for hepatitis B, and "Gardasil" and "Cervarix" and both are the licensed VLP-based vaccine for human papillomavirus. Today, VLP based vaccines against hepatitis C virus, Ebola, Lassa virus, hantavirus, Marburg, SARS coronavirus, and Chikungunya virus, among others, are in various stages of development.
By source, the virus-like particles market is segmented into yeast, insect cell, plant, and others. Based on the source, the yeast segment will record dominating share for the overall market in the coming years. Yeast cells are frequently used for recombinant proteins expression and have been widely used for VLP vaccine production. This is mainly due to advantages such as rapid cell growth, high protein expression yield, easy scalability, cost-effective production, and high degree of post-translational modification (PTM) processes. The Food and Drug Administration (FDA) has approved two VLP-based vaccines - Engerix-B (HBV vaccine) and Gardasil (HPV vaccine) - produced using yeast expression systems.
By application, the virus-like particles market is segmented as vaccines and therapeutics. The vaccines segment would hold a considerable share of the market in 2021, and it is likely to continue its dominance in the market during the forecast period as well. VLP-based vaccines have been developed as an alternative to traditional vaccines owing to their safety, flexibility, and distinctive immunogenic properties. The transmission of infectious or deadly viruses such as HCV poses a serious threat to populations worldwide. The introduction of an HCV vaccine has been projected using simulation models in a high-risk population with posing a significant effect on reducing the incidence of HCV. For example, to avoid such situation, simulation model has been developed by the government focusing on vaccination program aiming to reduce incidences of HCV. Simulation models has proven track record of reducing hepatitis C prevalence through VLP vaccine. With even modest efficacy and coverage VLP vaccine significantly reduces the incidence of hepatitis C among the population as the vaccine has effectiveness up to 50-80% efficacy, targeted to high-risk intravenous drug users, could dramatically reduce HCV incidence among the population. Therefore, VLPs based vaccine represents a safe and highly immunogenic vaccine delivery platform that is able to induce a potent adaptive immune response.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the International Society for Stem Cell Application are among the primary and secondary sources referred to while preparing the report on the virus like particles (VLP’s) market.Reasons to Buy
The global virus-like particles (VLP’s) market is segmented based on product type, source, and application. Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease. The hepatitis segment would account for a large market share during 2021-2028. For instance, as per the data published by the Hepatitis B Foundations in 2021, about two billion people are infected with the hepatitis B virus worldwide. To counter such situation utilization of commercialized VLPs vaccines proved effective for hepatitis treatment. Examples of commercialized VLP vaccines are “Recombivax" and "Engerix". These two are the recently commercialized VLP-based vaccines for hepatitis B, and "Gardasil" and "Cervarix" and both are the licensed VLP-based vaccine for human papillomavirus. Today, VLP based vaccines against hepatitis C virus, Ebola, Lassa virus, hantavirus, Marburg, SARS coronavirus, and Chikungunya virus, among others, are in various stages of development.
By source, the virus-like particles market is segmented into yeast, insect cell, plant, and others. Based on the source, the yeast segment will record dominating share for the overall market in the coming years. Yeast cells are frequently used for recombinant proteins expression and have been widely used for VLP vaccine production. This is mainly due to advantages such as rapid cell growth, high protein expression yield, easy scalability, cost-effective production, and high degree of post-translational modification (PTM) processes. The Food and Drug Administration (FDA) has approved two VLP-based vaccines - Engerix-B (HBV vaccine) and Gardasil (HPV vaccine) - produced using yeast expression systems.
By application, the virus-like particles market is segmented as vaccines and therapeutics. The vaccines segment would hold a considerable share of the market in 2021, and it is likely to continue its dominance in the market during the forecast period as well. VLP-based vaccines have been developed as an alternative to traditional vaccines owing to their safety, flexibility, and distinctive immunogenic properties. The transmission of infectious or deadly viruses such as HCV poses a serious threat to populations worldwide. The introduction of an HCV vaccine has been projected using simulation models in a high-risk population with posing a significant effect on reducing the incidence of HCV. For example, to avoid such situation, simulation model has been developed by the government focusing on vaccination program aiming to reduce incidences of HCV. Simulation models has proven track record of reducing hepatitis C prevalence through VLP vaccine. With even modest efficacy and coverage VLP vaccine significantly reduces the incidence of hepatitis C among the population as the vaccine has effectiveness up to 50-80% efficacy, targeted to high-risk intravenous drug users, could dramatically reduce HCV incidence among the population. Therefore, VLPs based vaccine represents a safe and highly immunogenic vaccine delivery platform that is able to induce a potent adaptive immune response.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the International Society for Stem Cell Application are among the primary and secondary sources referred to while preparing the report on the virus like particles (VLP’s) market.Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the virus-like particles (VLP’s) market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global virus-like particles (VLP’s) market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Virus-like Particles Market - By Product Type
1.3.2 Global Virus-like Particles Market - By Source
1.3.3 Global Virus-like Particles Market - By Application
1.3.4 Global Virus-like Particles Market - By Geography
2. Global Virus-like Particles Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Virus-like Particles Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. Virus-like Particles Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Prevalence of Infectious Viral Diseases
5.1.2 Widening Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Availability of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Continuous Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Virus-like Particles Market- Global Analysis
6.1 Global Virus-like Particles Market Revenue Forecast and Analysis
6.2 Global Virus-like Particles Market, By Geography - Forecast and Analysis
7. Virus-like Particles Market Revenue and Forecasts To 2028- by Product Type
7.1 Overview
7.2 Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8. Virus-like Particles Market Revenue and Forecasts To 2028 - By Source
8.1 Overview
8.2 Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9. Virus-like Particles Market Revenue and Forecasts To 2028 - By Application
9.1 Overview
9.2 Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10. Virus-like Particles Market Revenue and Forecasts to 2028 - Geographical Analysis
10.1 North America: Virus-like Particles Market
10.1.1 Overview
10.1.2 North America: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Virus-like Particles Market, by Product Type, 2019-2028 (US$ Million)
10.1.4 North America Virus-Like Particles Market, by Source, 2019-2028 (US$ Million)
10.1.5 North America: Virus-like Particles Market, by Application, 2019-2028 (US$ Million)
10.1.6 North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Virus-like Particles Market, by Product Type, 2019-2028 (US$ Million)
10.1.6.1.4 US: Virus-like Particles Market, by Source, 2019-2028 (US$ Million)
10.1.6.1.5 US: Virus-like Particles Market, by Application, 2019-2028 (US$ Million)
10.1.6.2 Canada: Virus-Like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Virus-like Particles Market, by Product Type, 2019-2028 (US$ Million)
10.1.6.2.4 Canada: Virus-like Particles Market, by Source, 2019-2028 (US$ Million)
10.1.6.2.5 Canada Virus-Like Particles Market, by Application, 2019-2028 (US$ Million)
10.1.6.3 Mexico: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Virus-like Particles Market, by Product Type, 2019-2028 (US$ Million)
10.1.6.3.4 Mexico: Virus-like Particles Market, by Source, 2019-2028 (US$ Million)
10.1.6.3.5 Mexico: Virus-like Particles Market, by Application, 2019-2028 (US$ Million)
10.2 Europe: Virus-like Particles Market
10.2.1 Overview
10.2.2 Europe: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)
10.2.6.1 Germany: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Virus-Like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Virus-like Particles Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.4 Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.5 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.3.6.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
10.3.6.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.3.6.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.3.6.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Virus-Like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Virus-Like Particles Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa Virus-like Particles Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
10.4.4 Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.4.5 Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.4.6.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.4.6.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.4.6.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.4.6.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.4.6.4.5 Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.5 South and Central America Virus-like Particles Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.5.3 South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.5.4 South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.5.6.1 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.1.3 Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4 Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.5.6.1.5 Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.2.3 Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4 Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.5.6.2.5 Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Virus-like Particles Market- Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Virus-like Particles Market- Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Virus-like Particles Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South And Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Virus-like Particles Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dynavax Technologies
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Wantai BioPharm
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Serum Institute of India Pvt. Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BHARAT BIOTECH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 LG Chem
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 VBI Vaccines Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher
14.2 Glossary of Terms
List of Tables
Table 1. North America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Virus-Like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Virus-like Particles Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 4. US Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 6. US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 7. Canada: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Virus-Like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 13. Europe: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 21. France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 24. UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Virus-like Particles Market, by Source- Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 35. Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 37. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 38. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 39. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 42. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 43. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 45. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 59. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 60. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 62. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 63. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 65. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 75. Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 78. Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms: Virus-like Particles MarketList of Figures
Figure 1. Virus-like particles Market Segmentation
Figure 2. Virus-like particles Market Segmentation, By Region
Figure 3. Global Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Virus-like particles Market
Figure 5. Asia Pacific to Show Significant Growth during Forecast Period
Figure 6. Virus-like Particles Market, by Geography (US$ Million)
Figure 7. Global Virus-like Particles Market - Leading Country Markets (US$ Million)
Figure 8. Global Virus-like Particles Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Virus-like Particles Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Virus-like Particles Market - By Geography Forecast and Analysis - 2021- 2028
Figure 17. Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 18. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 22. Yeast: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Plant: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Insect Cell: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Others: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)
Figure 27. Vaccine: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. North America: Virus-like Particles Market, by Key Country - Revenue (2021) (US$ Million)
Figure 30. North America Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 32. US: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Canada: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Mexico: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Europe: Virus-like Particles Market, by Key Country - Revenue (2021) (US$ Million)
Figure 36. Europe: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 38. Germany: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. France: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. UK: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Italy: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Spain: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Rest of Europe: Virus-like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Asia Pacific Virus-like Particles Market Overview, by Country (2021)
Figure 45. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 47. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 50. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Asia Pacific: Virus-Like Particles Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 54. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 55. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 56. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 61. South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 63. Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. Rest of South and Central America: Virus-like Particles Market- Revenue and Forecast to 2028 (US$ Million)
Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
Figure 67. Impact of COVID-19 Pandemic in European Country Markets
Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 69. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 70. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 71. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Dynavax Technologies
- Sanofi
- Wantai BioPharm
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 163 |
| Published | November 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 4601.84 Million |
| Forecasted Market Value ( USD | $ 7858.82 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
